| Literature DB >> 23519255 |
Pedro Mena1, Luca Calani, Chiara Dall'Asta, Gianni Galaverna, Cristina García-Viguera, Renato Bruni, Alan Crozier, Daniele Del Rio.
Abstract
The comprehensive identification of phenolic compounds in food and beverages is a crucial starting point for assessing their biological, nutritional, and technological properties. Pomegranate (Punica granatum L.) has been described as a rich source of (poly)phenolic components, with a broad array of different structures (phenolic acids, flavonoids, and hydrolyzable tannins) and a quick, high throughput, and accurate screening of its complete profile is still lacking. In the present work, a method for UHPLC separation and linear ion trap mass spectrometric (MSn) characterization of pomegranate juice phenolic fraction was optimized by comparing several different analytical conditions. The best solutions for phenolic acids, anthocyanins, flavonoids, and ellagitannins have been delineated and more than 70 compounds have been identified and fully characterized in less than one hour total analysis time. Twenty-one compounds were tentatively detected for the first time in pomegranate juice. The proposed fingerprinting approach could be easily translated to other plant derived food extracts and beverages containing a wide array of phytochemical compounds.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23519255 PMCID: PMC6268091 DOI: 10.3390/molecules171214821
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Identification of phytochemical compounds by UHPLC-MSn in negative mode under different MS operating conditions and columns.
| Id. | Compounds | [M−H]− ( | MS2 ion fragments ( | MS3 ion fragments ( | BlueOrchid C18 | Hypersil Gold C18 | Kinetex PFP | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RT (min) | Exp. 1 | Exp. 2 | RT (min) | Exp. 1 | Exp. 2 | RT (min) | Exp. 1 | Exp. 2 | |||||
| L-Malic acid | 71 | 0.84 | x | 0.84 | x | 0.79 | x | ||||||
| Vanillic acid | 8.80 | x | 8.52 | x | 9.22 | x | |||||||
| Gallic acid | 125 | 2.91 | x | 4.78 | x | ||||||||
| Syringaldehyde | 151 | 8.66 | x | ||||||||||
| Citric acid | 111, 67 | 1.14 | x | x | 1.30 | x | x | 1.05 | x | x | |||
| Pinocembrin | 213, 211, 151, 187, 169 | 11.69 | x | ||||||||||
| Tryhydroxyflavone | 7.26 | x | |||||||||||
| Naringenin-like | 107, 151, 83, 65 | 9.20 | x | x | 9.04 | x | x | ||||||
| Phloretin | 123, 125, 151 | 10.55 | x | ||||||||||
| (+)-Catechin | 203, 227, 187, 161, 217 | 6.80 | x | 6.89 | x | 6.83 | x | ||||||
| (–)-Epicatechin | 203, 227, 187, 161, 217 | 7.20 | x | x | 7.30 | x | x | 7.14 | x | x | |||
| Hydroxybenzoic acid hexoside | 179, 137, 93 | 6.01 | x | ||||||||||
| Ellagic acid | 257, 229, 301, 284, 185 | 8.18 | x | x | 8.04 | x | x | 8.18 | x | ||||
| (+)-Gallocatechin | 164, 151, 137 | 6.08 | x | ||||||||||
| Vanillic acid-hexoside | 123, 152, 108 | 4.93 | x | x | |||||||||
| Galloyl-hexoside | 125, 169 | 1.60 | x | 1.60 | x | ||||||||
| Galloyl-hexoside | 125, 169 | 1.79 | x | x | 1.79 | x | x | 1.79 | x | x | |||
| Galloyl-hexoside | 125, 169 | 1.96 | x | 1.96 | x | x | |||||||
| Galloyl-hexoside | 211, 169 | 2.25 | x | x | 2.25 | x | x | 2.25 | x | ||||
| Galloyl-hexoside | 169 | 3.02 | x | ||||||||||
| Galloyl-hexoside | 211, 169 | 3.25 | x | 3.25 | x | x | 3.25 | x | |||||
| Pinoresinol | 136, 151 | 8.78 | x | ||||||||||
| Secoisolariciresinol | 165, 179, 223, 122, 315 | 7.80 | x | ||||||||||
| Citric acid derivative | 111, 155 | 1.00 | x | 1.40 | x | 1.58 | x | ||||||
| Coumaric acid derivative | 145, 119, 103, 89, 127 | 7.80 | x | 8.16 | x | 7.31 | x | ||||||
| Ellagic acid-pentoside | 300, 257, 229 | 7.93 | x | 7.72 | x | x | |||||||
| Phloretin-hexoside (Phlorizin) | 167 | 10.38 | x | ||||||||||
| Ellagic acid-deoxyhexoside | 300, 257, 229 | 7.99 | x | x | 7.81 | x | x | 7.77 | x | x | |||
| Kaempferol-hexoside | 257, 267, 229, 241 | 9.10 | x | ||||||||||
| Datiscetin-hexoside | 241, 257, 125, 217, 243 | 7.01 | x | 6.85 | x | x | 6.86 | x | |||||
| Dihydrokaempferol-hexoside | 259, 243, 269 | 7.32 | x | x | 7.49 | x | x | 7.18 | x | x | |||
| Ellagic acid-hexoside | 301, 257, 229 | 7.22 | x | x | 7.14 | x | x | 7.10 | x | x | |||
| Quercetin-hexoside | 179, 151, 257, 301, 273 | 8.46 | x | ||||||||||
| HHDP-hexoside | 301, 257, 229 | 1.06 | x | x | 1.21 | x | x | 1.06 | x | x | |||
| HHDP-hexoside | 301, 257, 229 | 1.37 | x | x | 1.51 | x | x | 1.37 | x | x | |||
| Digalloyl-hexoside | 193, 169, 271, 211, 313 | 2.85 | x | ||||||||||
| Syringetin hexoside | 312, 283 | 8.65 | x | 8.20 | x | 8.00 | x | ||||||
| Feruloyl coniferin | 193, 175, 217, 277 | 8.05 | x | ||||||||||
| Cyclolariciresinol hexoside | 344 | 10.17 | x | x | 8.16 | x | x | ||||||
| Secoisolariciresinol hexoside | 346, 165, 179, 313 | 8.62 | x | 8.73 | x | ||||||||
| Guaiacyl(8-5)ferulic acid hexoside | 338, 353, 413, 395, 371 | 9.24 | x | ||||||||||
| Punicalagin isomers | 301, 257, 229 | 6.42 | x | 6.42 | x | 6.42 | x | ||||||
| Punicalagin isomers | 301, 257, 229 | 6.75 | x | x | 6.75 | x | 6.75 | x | |||||
| Kaempferol rutinoside | 257, 267, 241 | 8.90 | x | ||||||||||
| Dehydro-galloyl-HHDP-hexoside | 301 | 7.76 | x | ||||||||||
| Galloyl-HHDP-hexoside | 301, 257, 229 | 4.59 | x | x | 4.11 | x | |||||||
| Galloyl-HHDP-hexoside | 301, 257, 229 | 7.08 | x | x | 7.22 | x | x | ||||||
| Galloyl-HHDP-gluconate (lagerstannin C) isomer | 301, 257, 229 | 1.70 | x | 1.96 | x | 2.30 | x | ||||||
| Trisgalloyl glucose | 481, 299, 301, 425 | 4.29 | x | ||||||||||
| Galloyl-HHDP-gluconate (lagerstannin C) isomer | 301 | 5.78 | x | x | 5.90 | x | 6.06 | x | |||||
| di(HHDP-galloylglucose)-pentose | 481, 301, 765, 721, 275 | 6.22 | x | 6.68 | x | 6.25 | x | ||||||
| Punicalin α/A | 299, 271 | 3.66 | x | x | 2.59 | x | x | 3.10 | x | x | |||
| Punicalin β/B | 299, 271 | 3.90 | x | x | 2.80 | x | x | 3.30 | x | x | |||
| Pedunculagin I isomer | 437, 419, 299, 275 | 3.48 | x | x | 3.53 | x | x | 5.64 | x | x | |||
| Pedunculagin I isomer | 301, 257, 229 | 5.57 | x | x | 5.16 | x | x | 5.57 | x | ||||
| Pedunculagin I isomer | 301, 257, 229 | 5.94 | x | x | 5.69 | x | x | 6.00 | x | ||||
| Pedunculagin I isomer | 301, 257, 229 | 6.53 | x | x | 6.53 | x | |||||||
| Pedunculagin I isomer | 301, 257, 229 | 6.65 | x | x | 6.65 | x | 6.55 | x | x | ||||
| Punicalagin isomer | 721, 575, 1047, 1021, 601 | 6.08 | x | x | 5.40 | x | x | 6.11 | x | ||||
| Punicalagin α | 601, 721 | 6.45 | x | x | 6.49 | x | x | ||||||
| Punicalagin β | 601, 721 | 6.75 | x | x | 6.71 | x | x | ||||||
| Digalloyl-gallagyl-hexoside | 597, 613, 301 | 9.56 | x | x | |||||||||
| Punicalagin-like | 781, 601, 575, 721 | 2.56 | x | 2.56 | x | x | |||||||
| Di(HHDP-galloylglucose)-pentose | 765, 907, 631, 1121, 1077 | 6.28 | x | 6.66 | x | 6.30 | x | ||||||
| Digalloyl triHHDP-diglucose (sanguiin H10) isomer | 597, 401, 301, 613, 533 | 6.75 | x | ||||||||||
Compounds identified by comparing retention times and MS data with those of reference compounds; compounds (tentatively) identified for the first time in pomegranate juice; fragment ions are listed in order of relative abundances; MS2 ions in bold were those subjected to MS3 fragmentation; Exp. 1, experimental conditions 1, Exp. 2, experimental conditions 2. Compounds 42, 43 and 51 appear as both mono- and doubly-charged molecular ions.
Figure 1Chemical structures of hydrolyzable tannins identified in pomegranate juice.
Figure 2(A) Chromatograms of punicalagin isomer (70), α-punicalagin (42) and β-punicalagin (43) in Full MS scan (m/z 1083) for pomegranate juice analyzed by BlueOrchid C18 column. Comparison of the two different analytical conditions: experimental conditions 1 (brown peaks) and experimental conditions 2 (black peaks). (B) MS spectra of α- and β-punicalagin using the two experimental conditions.
Figure 3MS2 and MS3 fragment ion spectra of pinoresinol (A and B), cycolariciresinol hexoside (C and D) and secoisolariciresinol hexoside (E and F).
Identification of phytochemical compounds by UHPLC-MSn in positive mode by different analytical columns.
| Id. | Compounds | [M]+ ( | MS2 ion fragments ( | MS3 ion fragments ( | BlueOrchid C18 | Hypersil Gold C18 | Kinetex PFP | |||
|---|---|---|---|---|---|---|---|---|---|---|
| RT (min) | RT (min) | RT (min) | ||||||||
| POS1 | Pelargonidin-3-glucoside | 6,40 | x | 6,12 | x | 6,22 | x | |||
| POS2 | Cyanidin-3-glucoside | 6,08 | x | 5,80 | x | 5,82 | x | |||
| POS3 | Delphinidin-3-glucoside | 5,80 | x | 5,52 | x | 5,50 | x | |||
| POS4 | Pelargonidin-3,5-diglucoside | 271 | 5,70 | x | 5,47 | x | 5,38 | x | ||
| POS5 | Cyanidin-3,5-diglucoside | 287 | 5,52 | x | 5,16 | x | 5,17 | x | ||
| POS6 | Delphinidin-3,5-diglucoside | 303 | 5,28 | x | 5,00 | x | 4,88 | x | ||
| POS7 | (epi)gallocatechin-cyanidin-3-hexoside | 423, 573, 329, 465, 287 | 5,13 | x | ||||||
Fragment ions are listed in order of relative abundances; MS2 ions in bold were those subjected to MS3 fragmentation.
Figure 4Venn diagrams showing the number of compounds identified in each column by using Experiment 1 conditions (on the left) and Experiment 2 conditions (on the right) as well as the number of compounds elucidated by both negative mode conditions (in the center).
Figure 5Chromatograms of punicalagins in full MS Scan of the three analytical columns.